Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence.
about
Vascular endothelial growth factor receptor-2: counter-regulation by the transcription factors, TFII-I and TFII-IRD1DNA-binding and regulatory properties of the transcription factor and putative tumor suppressor p150(Sal2).Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury.Identification of synthetic endothelial cell-specific promoters by use of a high-throughput screen.Acceleration of thrombomodulin gene transcription by retinoic acid: retinoic acid receptors and Sp1 regulate the promoter activity through interactions with two different sequences in the 5'-flanking region of human gene.Screening of the transcriptional regulatory regions of vascular endothelial growth factor receptor 2 (VEGFR2) in amyotrophic lateral sclerosis.Transcription of human resistin gene involves an interaction of Sp1 with peroxisome proliferator-activating receptor gamma (PPARgamma)SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites.Structural and functional characterization of the leukocyte integrin gene CD11d. Essential role of Sp1 and Sp3.Vascular endothelial growth factor receptor-2 in breast cancer.Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer.O-GlcNAc Modification: Friend or Foe in Diabetic Cardiovascular Disease.The NFY transcription factor inhibits von Willebrand factor promoter activation in non-endothelial cells through recruitment of histone deacetylases.O-GlcNAc modification of transcription factor Sp1 mediates hyperglycemia-induced VEGF-A upregulation in retinal cells.Vascular endothelial growth factor receptor-2 expression is down-regulated by 17beta-estradiol in MCF-7 breast cancer cells by estrogen receptor alpha/Sp proteinsRegulation of human dihydropyrimidine dehydrogenase: implications in the pharmacogenetics of 5-FU-based chemotherapy.Central role of Sp1-regulated CD39 in hypoxia/ischemia protection.Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system.Regulation of transcription of the Dnmt1 gene by Sp1 and Sp3 zinc finger proteins.GC box-binding transcription factors control the neuronal specific transcription of the cyclin-dependent kinase 5 regulator p35.Sp3 is a transcriptional repressor of transforming growth factor-beta receptors.Ring-Sp1 decoy oligonucleotide effectively suppresses extracellular matrix gene expression and fibrosis of rat kidney induced by unilateral ureteral obstruction.Selective Sp1 and Sp3 binding is crucial for activity of the integrin alphaV promoter in cultured endothelial cells.17beta-estradiol enhances heparin-binding epidermal growth factor-like growth factor production in human keratinocytes.Downregulation of TNF-alpha and VEGF expression by Sp1 decoy oligodeoxynucleotides in mouse melanoma tumor.Molecular characterization of the constitutive expression of the plasma platelet-activating factor acetylhydrolase gene in macrophages.Promoter cloning and characterization of the anti-vascular proliferation gene, R-ras: role of Ets- and Sp-binding motifs.Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites.Sp1 and Sp3 mediate NHE2 gene transcription in the intestinal epithelial cells.Regulation of human CETP gene expression: role of SP1 and SP3 transcription factors at promoter sites -690, -629, and -37.Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor.Transforming growth factor-beta 1-mediated inhibition of the flk-1/KDR gene is mediated by a 5'-untranslated region palindromic GATA site.Sp1 and Sp3 activate p21 (WAF1/CIP1) gene transcription in the Caco-2 colon adenocarcinoma cell line.Regulation of the human Na(+)-glucose cotransporter gene, SGLT1, by HNF-1 and Sp1.The CD14 C-159T polymorphism is not associated with asthma or asthma severity in an Australian adult population.Activation of apolipoprotein AI gene expression by protein kinase A and kinase C through transcription factor, Sp1.Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3.Age-specific relationship between CD14 and atopy in a cohort assessed from age 8 to 25 years.Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers.
P2860
Q28255050-AD619A30-4B25-4BBF-AD10-EF2B09E146ECQ30179448-FF5B9CE2-2BD9-422D-A848-C785D9CBA474Q30306339-79E78A4D-C8C4-41EA-9600-D48512B67794Q31066742-1B316DA2-A40F-47C2-8CBC-2F2D103D7E1FQ31468454-E3E5CC88-A391-44E3-808A-CADAD30F2A4CQ33282666-7F45A8E9-58A4-431C-ADAB-685C5A0C0447Q33548739-8E38A3C2-F2E1-40EE-A2A2-0D1117D9409CQ33756417-57D97F3A-B278-4BE9-9113-9CA29059BB70Q33851925-6BB2E6C1-9D6E-474C-86AF-FFE47F21F1E8Q33893751-AC4EE990-89BD-4FBB-8C5C-698B6B7DFCC6Q33912620-D91F0A4D-534D-4A67-8BF2-7BC04DC0F833Q33952921-FE2947BF-39B3-4FA9-A519-B2F761F506FDQ34101859-0FCCC49E-CF97-4AB9-819B-28890EA4D2CCQ34168378-8FBB1F96-093E-4DB6-A4EC-B1281DB99B15Q35970441-700E431D-6762-4EB4-A41F-5A278CCBBF2EQ36447447-0F1FAC6C-80A4-4413-B7CE-B279AF3CB7C4Q36745681-B0B89C65-09C8-4639-8644-08855DC1BABBQ37039131-89A54AE9-15EB-4D2A-8862-8C75DF947AE6Q37088282-5BBE9A42-A0D5-4C96-9455-4EAD28EC6A54Q38288017-A78E83E0-05C5-4B28-AA12-45CE1FC9646EQ38294385-B7151277-2662-424E-8A1B-064B894639A1Q38307760-9320C036-8A52-47F8-9E9A-57B5B10EA46CQ38317847-01B547F1-ACE8-42F4-A6C2-6A576FBB7756Q38320011-95777985-3226-42CA-B547-ED151F02B219Q38329513-DE05A77B-D051-4DB2-BAC4-4AF05476782AQ38349602-15374539-5216-46CD-A0CF-1B727164F626Q38352665-BAAD457F-6C19-495E-8A8B-8992D7354E05Q38358968-4F8A9EFB-B6C7-4CF6-B322-F147839E865EQ38360640-89A11BBB-3205-450B-8EE5-71CD4BD8EBD6Q40155351-55FC9333-18AD-44B8-9BF3-5E2DCAC2001BQ40650133-3BD76221-EE31-4689-9D7B-8C44726B2EB6Q40730311-B195C244-F0FE-4117-851F-8D53EFBC6FEDQ40839613-22C13672-30BA-4CBD-B975-05B4A12747F7Q40844112-AA16470B-4630-4992-AADA-94E51F6D459CQ40887384-36D165FA-B8B1-4314-8C32-1C648FA69F7FQ41859300-4DCAE870-EBC8-4EFE-8F35-52FD4A720AECQ42488544-B69EC97D-3B9C-4E69-BC1B-FB98F7559521Q42507061-2DB65460-60E7-4A6D-9B54-B05159A5A2B9Q44655796-572F4A59-FB7F-4270-B83A-D3EA261DC7D6Q45868433-D2DDECE7-E186-43EB-84E6-6E1A138A243D
P2860
Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Transcription factors Sp1 and ...... a novel recognition sequence.
@en
type
label
Transcription factors Sp1 and ...... a novel recognition sequence.
@en
prefLabel
Transcription factors Sp1 and ...... a novel recognition sequence.
@en
P2093
P2860
P356
P1476
Transcription factors Sp1 and ...... a novel recognition sequence.
@en
P2093
P2860
P304
19294-19303
P356
10.1074/JBC.273.30.19294
P407
P577
1998-07-01T00:00:00Z